Cargando…

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation

Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer that is both common and aggressive, with a rising incidence in recent decades. Hypoxia is a key factor that plays a vital role in the tumorigenesis and metastasis of malignancy. However, the precise mechanisms of hypoxia driving ccRC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tao, Xiang, Wan, Chen, Zhizhuang, Wang, Gang, Cao, Rui, Zhou, Fenfang, Meng, Zhe, Luo, Yongwen, Chen, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679098/ https://www.ncbi.nlm.nih.gov/pubmed/38008826 http://dx.doi.org/10.1038/s41419-023-06298-7

Ejemplares similares

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
por: Zhang, Peng, et al.
Publicado: (2023)

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis
por: Chen, Liang, et al.
Publicado: (2019)

Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma
por: Song, Ye, et al.
Publicado: (2017)

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

Roles of PLODs in Collagen Synthesis and Cancer Progression
por: Qi, Yifei, et al.
Publicado: (2018)

DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis
por: Luo, Yongwen, et al.
Publicado: (2022)

PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway
por: Lan, Jiawen, et al.
Publicado: (2023)

Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma
por: Cao, Congcong, et al.
Publicado: (2021)

Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
por: Luo, Yongwen, et al.
Publicado: (2019)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
por: Luo, Li, et al.
Publicado: (2023)

Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
por: Shao, Yingkuan, et al.
Publicado: (2021)

FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
por: Jiang, Kun, et al.
Publicado: (2023)

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021)

PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019)

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
por: Wang, Zhen, et al.
Publicado: (2022)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang, Huiming, et al.
Publicado: (2021)

PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
por: Sheng, Xiaoli, et al.
Publicado: (2019)

Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinoma
por: Wang, Danwen, et al.
Publicado: (2023)

Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma
por: Wang, Bin, et al.
Publicado: (2022)

Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling
por: Wang, Zhenlin, et al.
Publicado: (2021)

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021)

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
por: Xu, Jinming, et al.
Publicado: (2023)

The PLOD2/succinate axis regulates the epithelial–mesenchymal plasticity and cancer cell stemness
por: Tong, Yuxin, et al.
Publicado: (2023)

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
por: Kreße, Nina, et al.
Publicado: (2022)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
por: Liu, Yadong, et al.
Publicado: (2021)

PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma
por: Deng, Xianyu, et al.
Publicado: (2021)

COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway
por: Gao, Shenglin, et al.
Publicado: (2021)

Characterisation of the Drosophila procollagen lysyl hydroxylase, dPlod
por: Bunt, Stephanie, et al.
Publicado: (2011)

Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020)

Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
por: Wang, Xiaoyan, et al.
Publicado: (2020)

Expression of AKT1 Related with Clinicopathological Parameters in Clear Cell Renal Cell Carcinoma
por: Choi, Taesoo, et al.
Publicado: (2022)

LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway
por: Zhang, Xiao, et al.
Publicado: (2022)

Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma
por: Chen, Hualin, et al.
Publicado: (2021)

Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
por: Shenoy, Niraj
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o6anj17i7os6gllokvmps4rdoi